OneSource Specialty Pharma Limited — research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for OneSource Specialty Pharma Limited, explained in plain English.

• ▪OneSource Specialty Pharma Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪Reported fundamentals show a net margin of -3.15%, debt to equity of 25.79.
• ▪Our transparent MaxGrade checklist scores it F (29/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 41.97% with a maximum drawdown of -41.05%.

Last traded values from 6 Oct 2026. Market closed.